Remodelin - Acetyl-transferase NAT10 Inhibitor. CAS# 949912-58-7 Catalog No.:M60187-10S Combined inhibition of EGFR and

Combined inhibition of EGFR and CK2 augments the attenuation of PI3K-Akt-mTOR signaling and the killing of cancer cells

compared with bortezomib

atherosclerosissup

selective aurora a kinase inhibitor

CPI-169 selectively affects the turnover of trimethylated

Remodelin - Acetyl-transferase NAT10 Inhibitor. CAS# 949912-58-7 Catalog No.:M60187-10S Combined inhibition of EGFR andRemodelin, CAS No. 949912 58 7, is a novel potent and selective inhibitor of the acetyl transferase protein NAT10. It can improve nuclear architecture, chromatin organization, and fitness of both human lamin A C depleted cells and HGPS derived patient cells, and decrease markers of DNA damage in these cells. Using a combination of chemical, cellular, and genetic approaches, acetyl transferase protein NAT10 was identified as the target of Remodelin